Skip to search formSkip to main contentSkip to account menu

BRCA1 Ag:PrThr:Pt:Tiss:Ord:Immune stain

Known as: BRCA1 , Ag:PrThr:Pt:Tessuto:Ord:Colorazione immunologica, BRCA1 Ag:PrThr:Moment:Weefsel en uitstrijkjes:Ordinaal:Immunokleuring, BRCA1 antigène [Arbitraire/Volume] Tissu ; Qualitatif ; Coloration immune 
National Institutes of Health

Related topics

Related topics

6 relations
AntigensBRCA1 geneBody tissueImmune stain

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Investigation into the origins of an ancient BRCA1 founder mutation identified among Chinese families in Singapore
Identification of ancestry‐specific pathogenic variants is imperative for diagnostic, treatment, management and prevention… 
2017
2017
Competitive PCR-High Resolution Melting Analysis (C-PCR-HRMA) for large genomic rearrangements (LGRs) detection: A new approach to assess quantitative status of BRCA1 gene in a reference laboratory.
2017
2017
Evaluation of BRCA1 Large Genomic Rearrangements in Group of Egyptian Female Breast Cancer Patients Using MLPA.
INTRODUCTION Breast cancer is one of the most widespread cancers affecting women all over the world. In Egypt, it is considered… 
2015
2015
Identification of a recurrent BRCA1 exon 21‐22 genomic rearrangement in Malay breast cancer patients
To the Editor: Germline mutations in BRCA1 and BRCA2 are associated with increased risk to breast and ovarian cancer and their… 
2013
2013
Breast cancer risk in BRCA 1 mutation carriers : insight frommouse models
Since its identification 20 years ago, the biological basis for the high breast cancer risk in women who have germline… 
2012
2012
Abstract PD09-02: BRCA1 insufficiency is predictive of superior survival in patients with triple negative breast cancer treated with platinum based chemotherapy
Introduction: Triple negative breast cancer (TNBC) and BRCA1 -associated breast cancers share many histopathologic and molecular… 
2008
2008
Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group
PurposeBRCA1 mutation carriers are at high risk for breast cancer (BC). The risk management strategy may include radiological… 
2007
2007
Prognostic value of BRCA1 mutations in familial breast cancer patients affected by a second primary cancer
The aim of this prospective study is to assess the prognostic value of BRCA1 mutations in familial breast cancer patients… 
2006
2006
The BRCA1 COOH-terminal Region Acts as an RNA Polymerase II Carboxyl-terminal Domain Kinase Inhibitor That Modulates p21WAF1/CIP1 Expression*
BRCA1 is involved both in positive and negative regulation of gene activity as well as in numerous other processes, such as DNA… 
1996
1996
Breast Cancer Susceptibility Genes: Current Challenges and Future Promises
Recent advances in understanding the basis for breast cancer that clusters in families represent a rare combination of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)